Radiology Grand Rounds Lecture Series

Duke Radiology Grand Rounds Lectures are conducted on Thursdays at 7:30 a.m.- 8:30 a.m. in Room 2002 Duke North. The mission for Radiology Grand Rounds is to provide an educational format which has a broad appeal to faculty and trainees. If you have any further questions regarding Radiology Grand Rounds, please contact Debbie Griffin at 919-684-7228.

 2019 Schedule

Personalized Breast Imaging

January 17, 2019 7:30 a.m. Duke North Room 2002

What is the future of Breast Cancer Screening?

Elizabeth Morris, M.D.

Professor of Radiology, Weill Cornell Medical College
Chief of Breast Imaging; Larry Norton Endowed Chair,
Memorial Sloan Kettering Cancer Center

Dr. Morris graduated summa cum laude from the University of California, Davis in Biochemistry and received her medical degree from the University of California, San Francisco. She completed her residency at Weill Cornell Medical College and a body/breast imaging fellowship at Memorial Sloan Kettering Cancer Center, where she has since remained on faculty.

Dr. Morris is a fellow of the American College of Radiology, Society of Breast Imaging (SBI) and International Society of MR in Medicine (ISMRM) and is past president of the SBI. She is the inaugural Equity Diversity & Inclusion officer of the ISMRM and co-chair of the Women of ISMRM.

In collaboration with her colleagues, she has authored over 160 papers, 40 book chapters, and 4 textbooks on breast disease, with an emphasis on the use of MRI. She has lectured nationally and internationally at over 300 conferences. She has grants from NCI, RSNA, Komen Foundation, and Breast Cancer Research Foundation. The focus of her recent research efforts is investigating imaging biomarkers to assess risk and treatment response.

Leading and Succeeding in an Age of Disruption

January 24, 2019 7:30 a.m. Duke North Room 2002

Today’s complex challenges require collaboration and increased focus on sense-making. This session will highlight key trends in leadership and culture building, drawing on Sanyin’s experiences in working with leaders from industry, sports, tech, and military. A theme through Sanyin’s work is convening interdisciplinary, diverse think tank gatherings towards defining complex problems and implementing new approaches for solving them. Learn from her experience as a leadership coach and from the smart practical field guide contained in her award-winning book titled, The Launch Book: Motivational Stories to Launch Your Idea, Business or Next Career.

Sanyin Siang, M.B.A.

Executive Director, Coach K Leadership & Ethics Center, Fuqua School of Business
Adjunct Associate Professor, Pratt School of Engineering
Duke University

As an executive coach, Sanyin Siang works with CEOs, Generals, and Olympic champions. She is one of 4 external advisors for GV (formerly Google Ventures), the Sports Innovation Lab, and Duke CE. Her thought leadership has appeared in Forbes, Fortune, The Wall Street Journal, New York Times, and CNN. She is a LinkedIn 2017 and 2018 Top 20 Global Influencer with 1 million+ followers.

She has served on the National Board of the Duke Children’s Hospital & Health Center, the Governing Board of the Emily Krzyzewski Center and the Museum of Life & Science. She has spoken to influencer audiences including at The White House and the Global Sports Owners Summits. Sanyin received a BSE in Biomedical Engineering and an MBA from Duke University. Sanyin is the author of The Launch Book: Motivational Stories for Launching Your Idea, Business or Next Career, which inspires readers through stories of different leaders and gives them an action plan for leveraging change using behavioral science concepts.

RadHacks: Leveraging Readily Available IT Solutions for Radiologists

January 31, 2019 7:30 a.m. Duke North Room 2002

The practice of Radiology is dependent on effective system utilization. Implementation is challenging due to variable system complexities, ongoing change, and a spectrum of organizational demands. Furthermore, there exists heterogeneity among divisional units and individual radiologists depending on a multitude of factors. The presentation will highlight available software and hardware tools that can be leveraged to maximize radiologist efficiency in different practice settings within the Duke Department of Radiology and beyond. We will discuss how tools can be synergistically employed to curtail inefficiency and increase value. Finally, we will examine how solutions can be adapted to evolving systems and radiologists with different technological backgrounds.

Nicholas Said, MD., MBA

Assistant Professor of Radiology, Musculoskeletal Imaging
Duke University

Dr. Nicholas Said is an Assistant Professor of Radiology in the Musculoskeletal Imaging Division at Duke University. After graduating with a degree in electrical engineering from Virginia Tech, he worked for Motorola in Austin, TX and Ottawa, Canada. He obtained his MBA from Virginia Tech, after which he worked at Symantec as a consultant before obtaining his medical degree at West Virginia University. Dr. Said completed radiology residency and fellowship in musculoskeletal imaging at the University of Virginia. Subsequently, he worked in private practice where he was appointed Director of IT before joining the Musculoskeletal Imaging Division at Duke.

Updates in Nuclear Imaging

February 14, 2019 7:30 a.m. Duke North Room 2002

Implementation and execution of precision medicine techniques continues to evolve. New and improved biomarkers along with genetic testing guide clinicians in selecting optimal patient-specific therapies. Nuclear and molecular imaging play a crucial role in establishing accurate diagnosis and prognosis as well as identifying viable therapeutic options. Recent advancements in oncologic molecular imaging techniques will allow diagnosis of micrometastatic disease that was previously undetectable. The FDA has recently approved multiple new radiotracers for clinical imaging. During this presentation, we will discuss the various diagnostic and therapeutic applications of these novel oncologic radiotracers.

Olga G. James, MD

Assistant Professor of Radiology, Nuclear Imaging
Duke University

Olga James is an Assistant Professor of radiology in nuclear imaging at Duke University. She is a graduate of Amur State Medical Academy in Russia. Dr. James completed training in internal medicine and cardiology and practiced as a general cardiologist in Russia, before moving to the United Stated in 1997. She went on to complete a cardiac MRI fellowship and nuclear medicine residency, both at Duke. Dr. James has authored numerous peer-viewed articles in both cardiology and nuclear imaging and was a 2017 recipient of the Clinician Educator Development Program Grant from the American Roentgen Ray Society. Outside of work, she enjoys spending time with her husband, two children, and dog.

Cancer Screening, Breast Surgery, and the Hippocratic Oath: a Cautionary Tale

February 21, 2019 7:30 a.m. Duke North Room 2002

Over 62,000 women in the United States will be diagnosed with ductal carcinoma in situ (DCIS) this year alone, almost all of these diagnoses made in completely asymptomatic individuals on screening mammography. It has been estimated that without treatment, only 20-30% of DCIS progress to invasive cancer in the long term. In those women who don’t progress, treatment can only result in harm without offering any benefit. The central role of breast imaging as a cause and as a promising research tool is a topic of active investigation as researchers seek to mitigate breast cancer overtreatment through a highly multidisciplinary approach.

Shelley Hwang, MD, MPH

Chief of Breast Surgery
Professor, Surgical Oncology and Radiology
Vice Chair of Research, Department of Surgery and Comprehensive Cancer Center
Duke University

Dr. Shelley Hwang is Professor of Surgical Oncology and Radiology, Chief of Breast Surgery and Vice Chair of Research for the Duke Department of Surgery and the Duke University Comprehensive Cancer Center, where she co-leads the Women’s Cancer Program. Her national leadership roles include membership on the NCI Breast Cancer Steering Committee and the NCCN Screening Guidelines Committee and she has also participated on national guidelines panels for DCIS and node-positive breast cancer. Her research focus includes breast cancer prevention, identifying less invasive treatments for early stage breast cancers including DCIS, and understanding the genetic and stromal determinants of cancer progression. She is collaborating to investigate breast cancer immunotherapy and her team has been funded to study PVSRIPO vaccine therapy for advanced breast cancer. Dr. Hwang is an experienced clinical trialist with a 20-year interest in both the biology and treatment of early stage breast cancer and she is the national PI of a cooperative group study through the ALLIANCE, the COMET study, which evaluates the role of active surveillance compared to usual care for DCIS. She is co-PI on the CRUK PRECISION Grand Challenge project, an international, multi-center collaboration around reducing over-treatment in early stage breast cancer. Her group has been selected for the Precancer Atlas U01 award, one of the Moonshot initiatives.

Morbidity and Mortality (Private Conference)

February 28, 2019 7:30 a.m. Duke North Room 2002
Tracy A. Jaffe, MD

Breast Imaging and Beyond: the radiologist's evolving role in patient-centered care

March 21, 2019 7:30 a.m. Duke North Room 2002

Patient-centered care (PCC) is a care model in which patients and families partner with providers and care teams, collaborating in shared decision-making processes to optimize patient care and satisfaction. While breast imaging has been the traditional radiology leader in this approach to care, the current era of value-based care is prompting radiology departments to extend their focus on patient satisfaction to other areas of radiology, expanding the radiologist’s role in patient communication, education and shared decision making. This presentation will review current breast imaging research and practices for optimizing patient care, and describe recent proposals for expanding these practices to other areas of radiology, including adapting for diversity, targeted patient education, and furthering radiologist-patient communication, with a discussion of the need for radiologist resiliency during these transitions.

Mary Scott Soo, MD, FACR, FSBI

Professor of Radiology, Breast Imaging
Duke University Medical Center

Dr. Soo is an academic breast-imaging radiologist who is recognized nationally as a leader in enhancing patient experiences in breast imaging. Her early research at Duke evaluated silicone breast implant integrity and breast ultrasound technology; subsequent research expanded the use of ultrasound- stereotactic- and MRI-guided breast biopsies, shaping her latest research focus on women’s experiences and radiologist-patient communication during breast biopsies. She is a Fellow of the ACR and Society of Breast Imaging (SBI), currently serving on the SBI Patient Care Delivery Task Force, the Duke Radiology APT Committee and Committee for Inclusion and Diversity. She has recently authored a book chapter and review article on patient-centered care and optimizing patient experiences in breast imaging, and submitted an NIH RO1 application to study benefits of loving-kindness meditation during breast biopsies in a multi-institutional setting.

Update on Medical 3D Printing, including CPT codes

March 28, 2019 7:30 a.m. Duke North Room 2002

Medical 3D printing has been in use for over 20 years, but only over the past 5 years has it begun to be recognized at society organizations. The Radiological Society of North America (RSNA) created its first Special Interest Group (SIG) on 3D printing, and the group has provided stewardship for anatomic models. Recently, Category III CPT codes were approved for 3D printing; these codes will be active on July 1, 2019. This talk will provide some benchmarks in the field and provide challenges and opportunities for medical practitioners.

Frank Rybicki, MD, PhD, FAHA, FACR

Professor and Chair of Radiology
University of Ottawa and The Ottawa Hospital

Frank J. Rybicki, MD, PhD, is Professor and Chair of Radiology at the University of Ottawa and The Ottawa Hospital. Dr. Rybicki is the Medical Director for Imagia, a leader in artificial intelligence. He is also Chair of the American College of Radiology Appropriateness Criteria®. In 2007, Dr. Rybicki introduced wide-area detector CT to radiology. He also made the initial observation that contrast hemodynamics are related to blood flow. Both of these technologies are now globally used for patient care and research. Dr. Rybicki pioneered medical 3D printing in healthcare; he is the Editor-in-Chief of 3D Printing in Medicine and in 2014 he founded and was the first Chairperson of the Radiological Society of North America Special Interest Group on 3D printing.

Objective Tumor Response for Solid Neoplasms and Computer-Assisted Response Evaluation

April 11, 2019 7:30 a.m. Duke North Room 2002

Renal cell carcinoma metastases are vascular and anti-angiogenic agents have become first line therapy. Tumor size changes in response to anti-angiogenic therapy are often delayed and underestimate tumor response in patients with metastatic renal cell carcinoma. Objective response to systemic therapy, as measured on computed tomography, determines critical endpoints in patient care; however, there are wide differences in how tumor size and response are assessed in clinical trials versus clinical practice. Computer-assisted response evaluation (CARE) can be used to prevent errors and improve efficiency and communication in assessing objective tumor response in patients with metastatic disease

Brian C. Allen, MD

Associate Professor of Radiology, Abdominal Imaging
Duke University

Brian C. Allen, MD, is an Associate Professor of Radiology, in the Division of Abdominal Imaging, at Duke University Medical Center. He received his medical degree from the Medical College of Wisconsin, completed a diagnostic radiology residency at the Cleveland Clinic and a fellowship in abdominal radiology at Duke University. Dr. Allen spent four years as an assistant professor at Wake Forest University Baptist Medical Center, prior to returning to Duke University in 2015. Dr. Allen has an interest in evaluating objective response to targeted therapy for metastatic renal cell carcinoma and the use of computers to decrease errors in tumor response assessment.


April 18, 2019 7:30 a.m. Duke North Room 2002
Terrence Z. Wong, MD, PhD


April 25, 2019 7:30 a.m. Duke North Room 2002
Mark Baker, MD

Morbidity and Mortality (Private Conference)

May 9, 2019 7:30 a.m. Duke North Room 2002
Tracy A. Jaffe, MD


May 16, 2019 7:30 a.m. Duke North Room 2002
Timothy J. Amrhein, MD